Axil Capital: A venture capital firm specializing in early-stage biomedical and healthcare investments.
Location
ward area of Tokyo, Tokyo, JP
Founded
2017
Axil Capital is a venture capital firm specializing in early-stage investments within the biomedical and healthcare sectors. The firm focuses on identifying and nurturing innovative companies that have the potential to make significant advancements in medical technology and healthcare solutions. Axil Capital typically participates in Series B funding rounds, providing substantial financial support to help these companies scale and achieve their growth objectives.
Notable portfolio companies under Axil Capital's umbrella include pioneering firms in the biomedical and healthcare industries, though specific names are not provided. The firm is led by key partners with extensive experience and a strong track record in the sector. Axil Capital's investment philosophy centers on fostering innovation and supporting transformative healthcare solutions. Additionally, the firm offers unique value-add services such as strategic guidance, industry connections, and operational support to help portfolio companies navigate the complexities of the biomedical landscape.
Axil Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B1 (50.0%)
Series D1 (50.0%)
Stage Mix
Series B 50%Series D 50%
Concentration shown as share of disclosed investments by stage.
